Reed Smith is well positioned to provide counsel to businesses that are related to the distribution and manufacturing of medical marijuana products. With coordinated teams in the U.S., UK, and Europe and a deep bench of skilled attorneys who practice in nearly all aspects of law, our team is focused on providing advice – and is prepared to defend it in the courts. In the U.S., our practice supports food and beverage retailers, as well as retailers of cannabis and CBD products, in meeting state-specific and regulatory requirements. In the UK and Europe, we focus on licensing, regulation, and compliance within the wellness, health care, and pharmaceuticals industries.
We have advised cannabis industry clients – from start-ups to listed companies and professional advisors – on issues relating to federal, state, and municipal regulations; compliance and best practices; mergers and acquisitions; debt; structured and equity (public and private) financings; restructuring, insolvency, and workouts; FDA and hemp product compliance; stock exchange listings and public securities reporting; clinic and product licensing and approvals; insurance coverage; REIT and real estate transactions; dispute resolution; 280E and cross-border taxation; advertising, brand licensing, and endorsements; fund formation; banking and service provider regulatory issues; broker-dealer and underwriter compliance; product liability; intellectual property and data protection and privacy (including TCPA and ADA compliance); and import/export and customs.
Reed Smith only provides these services in jurisdictions where legal and ethically permitted.